Research Article
Protective Effect of Boswellic Acids against Doxorubicin-Induced Hepatotoxicity: Impact on Nrf2/HO-1 Defense Pathway
Table 1
Effect of three weekly doses of doxorubicin (6 mg/kg) alone or in combination with boswellic acids (125, 250, or 500 mg/kg/day) on serum ALT and AST in mice.
| |||||||||||||||||||||||||||
Mice were injected with doxorubicin (DOX, 18 mg/kg i.p.) in combination with boswellic acids (BAs, 125, 250, or 500 mg/kg). Data are mean ± SD, and analysis was done by one-way ANOVA followed by Tukey’s post hoc test. aCompared to the saline group. bCompared to the DOX group. cCompared to the doxorubicin + BAs (125 mg/kg) group. value < 0.05. |